Additionally, gene enrichment analysis demonstrated that the active ingredients have potential therapeutic benefits with regard to BC via multiple pathways, such as the HIF-1, TNF, P53, MAPK, PI3K/Akt, apoptosis, and bladder cancer pathways. The gene discussed is TP53; the disease is breast cancer.